Over the last decades, the prevalence of drug-resistance in Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, has increased. These findings have rekindled interest in elucidating the unique adaptive molecular and biochemistry physiology of Mycobacterium. The use of metabolite profiling independently or in combination with other levels of “-omic” analyses has proven an effective approach to elucidate key physiological/biochemical mechanisms associated with Mtb throughout infection. The following review discusses the use of metabolite profiling in the study of tuberculosis, future approaches, and the technical and logistical limitations of the methodology.
CITATION STYLE
Drapal, M., & Fraser, P. D. (2019, May 1). Metabolite profiling: A tool for the biochemical characterisation of Mycobacterium sp. Microorganisms. MDPI AG. https://doi.org/10.3390/microorganisms7050148
Mendeley helps you to discover research relevant for your work.